Tag: marketing expenses

Quarterly net revenues were RMB706.4 million (US$98.6 million)¹
Quarterly lidar shipments were 352,095 units
Quarterly net income was RMB44.1 million (US$6.2 million)

The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million.
Therefore, we are publishing again both the corrected notice and the amended report.

The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million.
Therefore, we are publishing again both the corrected notice and the amended report.

MANAGEMENT REPORT

Momentum accelerates with $1.5 million in revenue for H1 2025 and an order backlog of $1.6 million as of June 30, bringing the combined total to $3.1 million — already approaching full-year 2024 revenue, as new sales continue to ramp in the second half of 2025

LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2025.